NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced that it has entered into an agreement for GPS Cancer, the leading proteogenomic molecular test that helps guide treatment strategies including choice of standard chemotherapy for oncologists, with Asia Genomics, a leading provider and distributor ...
Read More »New brain cancer coalition announces precision medicine study
Philadelphia Coalition for a Cure (PC4C), a newly launched cooperative clinical diagnostics and research initiative announced that it will collaborate in a study together with Children’s Hospital of Orange County (CHOC) directed to the study and diagnosis of adult and pediatric ...
Read More »NantHealth and University of Utah Establish Heritage 1K Project to Discover Genetic Causes of 25 Rare and Common Diseases
(BUSINESS WIRE)–NantHealth, Inc., a leading next-generation, evidence-based, personalized healthcare company, today announced that it has partnered with the University of Utah in analyzing the entire genomic profiles of at least 1,000 individuals who have a history of rare and life-threatening diseases and conditions in ...
Read More »NantHealth and Allscripts to integrate genomic (DNA) and transcriptome (RNA) sequencing at point of care
CHICAGO, March 2, 2015 (GLOBE NEWSWIRE) — NantHealth and Allscripts (Nasdaq:MDRX) will collaborate on the development and delivery of cutting-edge, precision medicine solutions directly to the point of care. The companies will introduce an integrated, evidence-based, personalized approach to ...
Read More »The Country’s First Health Network for Clinical Whole Genomic & Transcriptomic Sequencing
CULVER CITY, Calif.–(Business Wire)–NantHealth and The Chan Soon-Shiong Institute of Molecular Medicine founder and Chairman Dr. Patrick Soon-Shiong today announced its partnership with Providence Health and Services to create the country’s first clinical genomic network for whole genomic sequencing. Together, ...
Read More »